Stocktoria
JOHNSON & JOHNSON JNJ
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1944-09-25
JOHNSON & JOHNSON insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2026-06-11 | Option exercise | 10,000 | $115.67 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2026-06-11 | Sell | 10,000 | $241.15 |
| REED JOHN C | EVP, Innovative Medicine, R&D | 2026-05-01 | Option exercise | 25,255 | — |
| REED JOHN C | EVP, Innovative Medicine, R&D | 2026-05-01 | Tax withheld | 11,002 | $229.85 |
Source: SEC EDGAR filings · CIK 0000200406 · as of 2025-12-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.